Taiwan - Delayed Quote TWD

Energenesis Biomedical CO.,LTD. (6657.TW)

Compare
50.90
+0.70
+(1.39%)
At close: 1:30:13 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Mr. Jen-yi Chiu Co-Founder & Chairman -- -- --
Dr. Han-min Chen Co-Founder, Vice Chairman & GM -- -- --
Ms. Pei-chao Chen Director of Accounting -- -- --
Mr. Ming-tsan Chiang VP, Corporate Governance Officer & Director of the General Administrative Division -- -- --

Energenesis Biomedical CO.,LTD.

No.21, Ln.583, Ruiguang Road
6F.-3, Neihu Dirstrict
Taipei, 11492
Taiwan
886 2 2627 0835 https://www.energenesis-biomedical.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
35

Description

Energenesis Biomedical CO.,LTD. operates in the biomedicine industry in Taiwan. It provides ENERGI-F703, which is Phase II clinical trial for use in treatment of diabetic foot ulcers; ENERGI-F701, a topical tonic for the treatment of alopecia that is in Phase II clinical trial; ENERGI-F711, a burn cream; ENERGI-F702 to treat metabolic diseases; ENERGI-F704 for the treatment of inflammatory bowel disease; ENERGI-F708 for asthma treatment; ENERGI-F705 for Parkinson's disease control; ENERGI-F707 for the treatment of mitochondria deficiency; ENERGI-F706 to treat cachexia; ENERGI-F709, a vaccine adjuvant; and ENERGI-F710 for blood phosphate control. The company also offers scientific products, which include western blot, cell culture supplement, protein isolation, protein quantification, dyes, and buffer solutions. Energenesis Biomedical CO.,LTD. was founded in 2012 and is based in Taipei, Taiwan.

Corporate Governance

Energenesis Biomedical CO.,LTD.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers